278 related articles for article (PubMed ID: 30348603)
21. An association between preoperative anemia and decreased survival in early-stage non-small-cell lung cancer patients treated with surgery alone.
Yovino S; Kwok Y; Krasna M; Bangalore M; Suntharalingam M
Int J Radiat Oncol Biol Phys; 2005 Aug; 62(5):1438-43. PubMed ID: 16029805
[TBL] [Abstract][Full Text] [Related]
22. Segmentectomy versus wedge resection for the treatment of high-risk operable patients with stage I non-small cell lung cancer: a meta-analysis.
Hou B; Deng XF; Zhou D; Liu QX; Dai JG
Ther Adv Respir Dis; 2016 Oct; 10(5):435-43. PubMed ID: 27585599
[TBL] [Abstract][Full Text] [Related]
23. A Panel of Genetic Polymorphism for the Prediction of Prognosis in Patients with Early Stage Non-Small Cell Lung Cancer after Surgical Resection.
Lee SY; Choi JE; Jeon HS; Choi YY; Lee WK; Lee EB; Lee HC; Kang HG; Yoo SS; Lee J; Cha SI; Kim CH; Lee MH; Kim YT; Jheon S; Park JY
PLoS One; 2015; 10(10):e0140216. PubMed ID: 26462029
[TBL] [Abstract][Full Text] [Related]
24. Sarcopenia predicts prognosis of patients with renal cell carcinoma: A systematic review and meta-analysis.
Hu X; Liao DW; Yang ZQ; Yang WX; Xiong SC; Li X
Int Braz J Urol; 2020; 46(5):705-715. PubMed ID: 32213202
[TBL] [Abstract][Full Text] [Related]
25. Development and validation of a preoperative prognostic index independent of TNM stage in resected non-small cell lung cancer.
Kumagai S; Marumo S; Arita M; Yamanashi K; Sumitomo R; Otake Y; Shoji T; Fukui M; Katayama T; Okumura N; Huang CL
BMC Pulm Med; 2017 Dec; 17(1):166. PubMed ID: 29202834
[TBL] [Abstract][Full Text] [Related]
26. KRAS mutation is a weak, but valid predictor for poor prognosis and treatment outcomes in NSCLC: A meta-analysis of 41 studies.
Pan W; Yang Y; Zhu H; Zhang Y; Zhou R; Sun X
Oncotarget; 2016 Feb; 7(7):8373-88. PubMed ID: 26840022
[TBL] [Abstract][Full Text] [Related]
27. Prognostic significance of pre-resection albumin/fibrinogen ratio in patients with non-small cell lung cancer: A propensity score matching analysis.
Chen S; Yan H; Du J; Li J; Shen B; Ying H; Zhang Y; Chen S
Clin Chim Acta; 2018 Jul; 482():203-208. PubMed ID: 29653085
[TBL] [Abstract][Full Text] [Related]
28. The prognostic impact of tumor volume on stage I non-small cell lung cancer.
Su XD; Xie HJ; Liu QW; Mo YX; Long H; Rong TH
Lung Cancer; 2017 Feb; 104():91-97. PubMed ID: 28213008
[TBL] [Abstract][Full Text] [Related]
29. Association of Low Body Mass Index With Poor Clinical Outcomes After Resection of Non-small Cell Lung Cancer.
Takada K; Shimokawa M; Akamine T; Ono Y; Haro A; Osoegawa A; Tagawa T; Mori M
Anticancer Res; 2019 Apr; 39(4):1987-1996. PubMed ID: 30952742
[TBL] [Abstract][Full Text] [Related]
30. Clinical utility of psoas muscle volume in assessment of sarcopenia in patients with early-stage non-small cell lung cancer.
Yamada Y; Shimada Y; Makino Y; Kudo Y; Maehara S; Yamada T; Hagiwara M; Kakihana M; Ohira T; Ikeda N
J Cancer Res Clin Oncol; 2023 Jul; 149(7):3277-3285. PubMed ID: 35916994
[TBL] [Abstract][Full Text] [Related]
31. Lymphadenectomy for clinical early-stage non-small-cell lung cancer: a systematic review and meta-analysis.
Meng D; Zhou Z; Wang Y; Wang L; Lv W; Hu J
Eur J Cardiothorac Surg; 2016 Oct; 50(4):597-604. PubMed ID: 27107044
[TBL] [Abstract][Full Text] [Related]
32. Prognostic significance of combined pulmonary fibrosis and emphysema in patients with resected non-small-cell lung cancer: a retrospective cohort study.
Kumagai S; Marumo S; Yamanashi K; Tokuno J; Ueda Y; Shoji T; Nishimura T; Huang CL; Fukui M
Eur J Cardiothorac Surg; 2014 Dec; 46(6):e113-9. PubMed ID: 25345566
[TBL] [Abstract][Full Text] [Related]
33. Effectiveness and safety of bevacizumab for unresectable non-small-cell lung cancer: a meta-analysis.
Yang K; Wang YJ; Chen XR; Chen HN
Clin Drug Investig; 2010; 30(4):229-41. PubMed ID: 20225906
[TBL] [Abstract][Full Text] [Related]
34. The prognostic impact of sarcopenia on elderly patients undergoing pulmonary resection for non-small cell lung cancer.
Miura A; Yamamoto H; Sato H; Tomioka Y; Shiotani T; Suzawa K; Miyoshi K; Otani S; Okazaki M; Sugimoto S; Yamane M; Toyooka S
Surg Today; 2021 Jul; 51(7):1203-1211. PubMed ID: 33559731
[TBL] [Abstract][Full Text] [Related]
35. Prognostic role of platelet to lymphocyte ratio in non-small cell lung cancers: A meta-analysis including 3,720 patients.
Zhao QT; Yuan Z; Zhang H; Zhang XP; Wang HE; Wang ZK; Duan GC
Int J Cancer; 2016 Jul; 139(1):164-70. PubMed ID: 26915723
[TBL] [Abstract][Full Text] [Related]
36. Prognostic and clinicopathological significance of downregulated E-cadherin expression in patients with non-small cell lung cancer (NSCLC): a meta-analysis.
Yang YL; Chen MW; Xian L
PLoS One; 2014; 9(6):e99763. PubMed ID: 24978478
[TBL] [Abstract][Full Text] [Related]
37. LUNX mRNA-positive cells at different time points predict prognosis in patients with surgically resected nonsmall cell lung cancer.
Li J; Shi SB; Shi WL; Wang Y; Yu LC; Zhu LR; Ge LP
Transl Res; 2014 Jan; 163(1):27-35. PubMed ID: 24120632
[TBL] [Abstract][Full Text] [Related]
38. Volume-Based Assessment With 18F-FDG PET/CT Improves Outcome Prediction for Patients With Stage IIIA-N2 Non-Small Cell Lung Cancer.
Hyun SH; Ahn HK; Ahn MJ; Ahn YC; Kim J; Shim YM; Choi JY
AJR Am J Roentgenol; 2015 Sep; 205(3):623-8. PubMed ID: 26295651
[TBL] [Abstract][Full Text] [Related]
39. Sarcopenia Predicts Prognosis of Patients Undergoing Liver Resection for Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis.
Zhang H; Zhang L; Wang Y; Zou J; Zhang T
Nutr Cancer; 2023; 75(3):776-784. PubMed ID: 36537813
[TBL] [Abstract][Full Text] [Related]
40. Prognostic factors after complete resection of pN2 non-small cell lung cancer.
Sonobe M; Date H; Wada H; Okubo K; Hamakawa H; Teramukai S; Matsumura A; Nakagawa T; Sumitomo S; Miyamoto Y; Okumura N; Takeo S; Kawakami K; Aoki M; Kosaka S;
J Thorac Cardiovasc Surg; 2013 Oct; 146(4):788-95. PubMed ID: 23810113
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]